U.S. federal trademark · Serial No. 50144503
Pharmaceutical research and development; Consulting services in the field of pharmaceutical research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials
Pharmaceutical preparations for the treatment of immune system related diseases and disorders, complement-mediated diseases and disorders, neurological diseases and disorders, and ophthalmic diseases and disorders; Pharmaceutical preparations for the treatment of Guillain-Barré syndrome, macular degeneration, geographic atrophy, Huntington's Disease, amyotrophic lateral sclerosis (ALS), lupus, cold agglutinin disease (CAD), chronic inflammatory demyelinating polyneuropathy (CIDP), and myasthenia gravis (MG)
Providing medical information; Providing medical information in the field of pharmaceuticals
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.